Regenxbio RGNX Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Regenxbio in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Regenxbio’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regenxbio's accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regenxbio's accrued expenses and other liabilities?
- Regenxbio (RGNX) reported accrued expenses and other liabilities of -$16.73M in Q1 2026.
- How has Regenxbio's accrued expenses and other liabilities changed year-over-year?
- Regenxbio's accrued expenses and other liabilities decreased by 15.5% year-over-year, from -$14.49M to -$16.73M.
- What is the long-term trend for Regenxbio's accrued expenses and other liabilities?
- Over 2 years (2021 to 2025), Regenxbio's accrued expenses and other liabilities has grown at a -91.2% compound annual growth rate (CAGR), from $29.91M to $229K.